The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Personalising transcranial magnetic stimulation for depression using neuroimaging: A systematic review
Abstract
Objectives Transcranial magnetic stimulation (TMS) is a well-established and effective treatment for depression, though response rates are suboptimal. Personalising TMS for depression with neuroimaging can take into account inter-individual differences in anatomical and electrophysiological characteristics; and thereby provide a potentially more efficacious form of treatment. The current systematic review aimed to critically appraise the literature relating to personalising TMS for depression with neuroimaging. Methods PubMed, PsycINFO and Embase databases were used to identify relevant literature published up to November 2020. Results A total of 37 studies were included in the review. Across these studies, a total of 1451 patients with depression received TMS that was personalised using neuroimaging. The majority of the studies used structural or functional neuroimaging to personalise treatment target ( n = 30), primarily through neuronavigation methodologies. Fewer studies used electroencephalography to personalise treatment frequency or stimulus timing ( n = 7). Only 6 studies directly compared neuroimaging-personalised TMS to standard TMS. Conclusions The findings from this review suggest that personalising TMS with neuroimaging may be more effective in the treatment of depression compared to standard TMS. Further research is required to directly compare neuroimaging-personalised TMS with standard TMS, and to identify the optimal parameters for treatment personalisation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Electrophysiological characteristics and neuroanatomy findings indicated that neuroimaging can identify patient-specific targets for DBS and transcranial magnetic stimulation, increasing treatment efficacy213, 214.”
From Dysregulation of adult hippocampal neuroplasticity in major depression: Pathogenesis and therapeutic implications (2022) · cites this paper as [213]
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042 · cited 1×
“Record selection was conducted in accordance with the PRISMA guidelines for reporting systematic reviews (Moher et al. 2009).”
Cochrane Handbook for Systematic Reviews of Interventions
(2019) · doi:10.1002/9781119536604 · Cited by 14,828
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643 · cited 1×
“Current treatments for depression are suboptimal (Rush et al. 2006), and there is a need to develop novel, efficacious treatments.”
BackgroundBlumberger, D. M., Vila-Rodriguez, F., Thorpe, K. E., Feffer, K., Noda, Y., Giacobbe, P., Knyahnytska, Y., Kennedy, S. H., Lam, R. W., Daskalakis, Z. J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30295-2 · Cited by 1,363 · cited 14×
“This included a mixture of RCTs, open-label studies, a retrospective chart review, and case reports; published from 2003 to 2020 (Table 1).”
BackgroundMethodResultInfluentialFox, M. D., Buckner, R. L., White, M. P., Greicius, M. D., & Pascual-Leone, A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.04.028 · Cited by 1,270 · cited 5×
“…functional connectivity antecorrelation with the subgenual anterior cingulate cortex (Fox et al. 2012), while another study (Blumberger et al. 2018) adopted the coordinates that were suggested to be potentially associated with better treatment outcomes in a different analysis by Fox et al. (2012).”
MethodResultInfluentialGeorge, M. S., Lisanby, S. H., Avery, D., McDonald, W. M., Durkalski, V., Pavlicova, M., Anderson, B., Nahas, Z., Bulow, P., Zarkowski, P., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.46 · Cited by 1,092 · cited 2×
“One study used structural MRI to personalise treatment target without using neuronavigation; instead, if the location determined by the standard 5 cm method was found to be in the premotor cortex, the target was moved forward by 1 cm prior to commencing treatment (George et al. 2010).”
BackgroundMethodDaily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression
George, M. S., Wassermann, E. M., Williams, W. A., Callahan, A., Ketter, T. A., Basser, P., Hallett, M., & Post, R. M. (1995) · NeuroReport · doi:10.1097/00001756-199510020-00008 · Cited by 954 · cited 2×
“muscle (George et al. 1995) or the BeamF3 method, which uses scalp and head measurements to define a target that corresponds with the F3 location in the international 10–20 electroencephalography (EEG) system (Beam et al.”
MethodInfluentialPatel, V., Chisholm, D., Parikh, R., Charlson, F. J., Degenhardt, L., Dua, T., Ferrari, A. J., Hyman, S., Laxminarayan, R., Levin, C., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00390-6 · Cited by 889 · cited 1×
“Depression is a common, debilitating mental disorder, and a leading cause of disease burden globally (Patel et al. 2016).”
BackgroundStanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression
Cole, E. J., Stimpson, K. H., Bentzley, B. S., Gulser, M., Cherian, K., Tischler, C., Nejad, R., Pankow, H., Choi, E., Aaron, H., et al. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19070720 · Cited by 802 · cited 12×
“The high remission rate reported in this study could be attributed to their unique treatment protocol, which used high dose, accelerated, intermittent TBS, personalised with functional connectivity guided MRI targeting, though this study was open-label and the results should be replicated using a double-blind sham-con…”
Influential
Research works printed but not linked: 3
- Cocchi L, 2018, Biol Psychiatry Cogn Neurosci Neuroimaging, 3, 731
- Tang N, 2010, Chin Mental Health J, 24, 435
- Thase ME, 1997, J Clin Psychiatry, 58, 23
Cited by
Tartt, A. N., Mariani, M. B., Hen, R., Mann, J. J., & Boldrini, M. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01520-y · Cited by 408
“Electrophysiological characteristics and neuroanatomy findings indicated that neuroimaging can identify patient-specific targets for DBS and transcranial magnetic stimulation, increasing treatment efficacy [212, 213].”
BackgroundAssessing the mechanisms of brain plasticity by transcranial magnetic stimulation
Jannati, A., Oberman, L. M., Rotenberg, A., & Pascual-Leone, A. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-022-01453-8 · Cited by 290
Caulfield, K. A., Fleischmann, H. H., Cox, C. E., Wolf, J. P., George, M. S., & McTeague, L. M. (2022) · Brain Stimulation · doi:10.1016/j.brs.2022.08.013 · Cited by 145
“Regarding where to stimulate, much attention has justifiably been given to personalizing the stimulation target, which appears to be clinically impactful [44] but must be tested further in future double blind studies.”
Evidence of Neuroplastic Changes after Transcranial Magnetic, Electric, and Deep Brain Stimulation
Kricheldorff, J., Göke, K., Kiebs, M., Kasten, F. H., Herrmann, C. S., Witt, K., & Hurlemann, R. (2022) · Brain Sciences · doi:10.3390/brainsci12070929 · Cited by 145
“Targets localized by functional and structural neuroimaging are becoming widely used and even real-time targeting of the brain’s fiber tracts through tractography-based TMS neuronavigation is currently being developed with promising results [23,24].”
BackgroundMiron, J., Jodoin, V. D., Lespérance, P., & Blumberger, D. M. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253211042696 · Cited by 108
Metadata
- Authors
- Modak, A., & Fitzgerald, P. B.
- Affiliations
- Epworth Hospital (AU)
- Corresponding author
- Modak, Anish
- Venue
- The World Journal of Biological Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2021-04-21
- Volume
- 22
- Issue
- 9
- Pages
- 647-669
- ISSN
- 1562-2975 (ISSN-L)
- 1814-1412
- OpenAlex
- W3147658218
- Cited by
- 56
- References
- 60
- Citations by year
- 2026: 11 · 2025: 7 · 2024: 10 · 2023: 15 · 2022: 10 · 2021: 3
- FWCI
- 1.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The World Journal of Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- transcranial magnetic stimulation, depression, personalized treatment, neuroimaging, neuronavigation, structural neuroimaging, functional neuroimaging, EEG, treatment target selection, treatment frequency, stimulus timing, treatment response
- MeSH terms
- Depression, Electroencephalography, Humans, Transcranial Magnetic Stimulation, Neuroimaging, Functional Neuroimaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Personalising transcranial magnetic stimulation for depression using neuroimaging: A systematic review. https://app.cochat.ai/papers/10.1080/15622975.2021.1907710
- The paper
- Modak, A., & Fitzgerald, P. B. (2021). Personalising transcranial magnetic stimulation for depression using neuroimaging: A systematic review. The World Journal of Biological Psychiatry. https://doi.org/10.1080/15622975.2021.1907710
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.